Intellectual property and access to vaccines during the Covid-19 pandemic

Partner Jason Jardine and Associate Justin Culbertson Ph.D. authored "Intellectual property and access to vaccines during the Covid-19 pandemic," which was published in International Bar Association.

Excerpt: "In late 2019 and early 2020, the world began to feel the effects of the Covid-19 virus. Within a few short months, a world-wide pandemic had been declared. Pharmaceutical and biotechnology companies, some newly infused with government money, began working in earnest to create diagnostics, treatments, and vaccines. Some companies, such as Moderna, had been working on mRNA vaccines for ten years, but refocused their efforts to specifically create a mRNA vaccine technology to create immunity against the Covid-19 virus."

Read the full article here >>